Leading the latest haul is Kimberly-Clark Corp., which has agreed to buy struggling Tylenol maker Kenvue Inc. for roughly $40 ...

Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

Kimberly-Clark is buying Tylenol maker Kenvue for nearly $50 billion. Wall Street isn’t too fond of the deal—for good reason.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

(Reuters) -Kleenex maker Kimberly-Clark said on Monday it will buy Kenvue for more than $40 billion in a landmark deal for ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

US consumer health company Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for ...

The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism.